Regression of left ventricular hypertrophy during antihypertensive treatment.
Left ventricular hypertrophy is a risk factor for cardiovascular events and stroke. It has been demonstrated that the regression of left ventricular hypertrophy (evaluated by 12-lead electrocardiography and by echocardiography) during antihypertensive treatment is associated with a lower risk of cardiovascular mortality and may thus improve the prognosis. Black people run a disproportionately high risk of developing essential arterial hypertension which frequently results in end organ damage, including left ventricular hypertrophy, haemorrhagic stroke and renal failure. We report a case of significant regression of left ventricular hypertrophy in a sub-Saharan African patient, during antihypertensive treatment.
Foading Deffo
Bertin
B
Department of Cardiology, Clinique Saint-Jean, Brussels, Belgium. foadingbertin@hotmail.com
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D044383:Black People; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000208:ethnology; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000208:ethnology; D008297:Male
D000959:Antihypertensive Agents